Cramer’s Investing Club Stock Profile: Drugmaker Abbvie deserves a

As we wait for the market to gain more appreciation for Abbvie, the roughly 4.15% dividend handsomely pays us for our patience.



Read More: Cramer’s Investing Club Stock Profile: Drugmaker Abbvie deserves a